Arrakis Therapeutics Company
Arrakis Therapeutics is a developer of a drug discovery platform intended to target RNA. The company's platform integrates leading-edge RNA bioinformatic and structural tools to produce a pipeline of rSMs to treat a range of disease including neurology, oncology and rare genetic diseases, enabling physicians to offer enhanced care.
Investors
.png)
.png)
.png)
.png)
.png)
(Reupload).png)
.jpg)
.png)
Technology:
Biopharma, Biotechnology, Medical, Pharmaceutical
Industry:
Early Drug Development
Headquarters:
Waltham, Massachusetts, United States
Founded Date:
2015-01-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
14
Total Funding:
113000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2019-04-18
Last Funding Type:
Series B
Register and Claim Ownership